田村 大輔 たむら だいすけ 先生

来歴等

略歴

2000年 北里大学医学部 医学科 卒業
2000年 自治医科大学 小児科 入局
2007年 自治医科大学 小児科 退職
2007年 東京大学医科学研究所のウイルス感染分野にてウイルスの基礎研究に従事。
2010年 Medical officerとして世界保健機関（ジュネーブ）で新型インフルエンザ診療ガイドライン作成に携わる。
2012年 Centers for Disease Control and Prevention（CDC：米国疾病管理予防センター）にてウイルスの基礎研究と公衆衛生に従事。
2015年 帰国。厚生労働省健康局
2016年 自治医科大学附属病院 卒後臨床研修センター 副センター長、自治医科大学小児科学講座 准教授

論文

• ❍;Corresponding author

• 1. Impact of the Omicron Phase on a Highly Advanced Medical Facility in Japan. Frontiers in Prdiatr. 2023 (in press)

  Yamagishi H, ❍Tamura D, Aoyagi J, Suzuki S, Mizobe Y, Wakae K, Yamagata T, Tajima T, Osaka H.

• 2. COVID-19 pathogenesis involving B cells and serum cytokines: A case report of hereditary bone marrow failure. J Clin Images Med Case Rep. 2023; 4(1): 2238.

  Tamura D, Mizobe Y, Tanimoto K, Kawahara Y, Yamagishi H, Shinjoh M, Yamagata T, Osaka H.

• 3. Omicron proliferation in the nasal cavity may explain its high infectivity. J Infect. 2023;86(6);584-587.

  Tamura D, Kawaoka Y.

• 4. Clinical picture of bacteremia with Staphylococcus pettenkoferi in children. J Clin Images Med Case Rep. 2023; 4(1): 2237.

  Tamura D, Kurane K, Koshu K, Shinjoh M, Tanaka D, Yamagishi H, Kimura Y, Nakazato E, Yamagata T

• 5. COVID-19 pathogenesis involving B cells and serum cytokines: A case report of hereditary bone marrow failure. J Clin Images Med Case Rep. 2023; 4(1): 2238.

  Tamura D, Mizobe Y, Tanimoto K, Kawahara Y, Yamagishi H, Shinjoh M, Yamagata T, Osaka H.

• 6. Diagnostic accuracy of a novel SARS CoV-2 rapid antigen test and usefulness of specimens collected from the anterior nasal cavity. Int J Infect Dis. 2022;124:199-205.

  Tamura D, Yamagishi H, Morisawa Y, Mato T, Nunomiya S, Maehara Y, Ochiai Y, Okuyama S, Ohmika N, Yamagata T, Osaka H.

• 7. Case Report: Anterior Scleritis Presenting as a Primary Ocular Manifestation in Multisystem Inflammatory Syndrome in Children With COVID-19. Front Pediatr. 2022;10:943652.

  Matsubara D, Tamura D, Kasuya Y, Mizobe Y, Hiwada M, Seki M, Makino S, Yamagata T.

• 8. Diagnosis and treatment of influenza based on health insurance claims between the 2010-2011 and 2019-2020 influenza seasons in Japan. Influenza Other Respir Viruses. 2022 Jul;16(4):621-625.

  Shimizu E, Iwasaki K, Hongo Y, Yoshida M, Kinoshita M, Hiroi S, ❍Tamura D.

• 9. Comparison of Inconvenience Costs Between Influenza Antivirals for Japanese Pediatric Patients: A Conjoint Analysis of Parental Responses. Adv Ther. 2022;39(4):1724-1742.

  Kurazono K, Ikeoka H, Hiroi S, Iwasaki K, Takeshima T, ❍Tamura D.

• 10. Lack of persisting antibody in a post-transplant patient after vaccine-strain varicella. Pediatr Transplant. 2021;25(7):e14070.

  Tamura D, Kurosaki M, Shinjoh M, Nishimura H, Yamagishi H, Yamagata T.

• 11. Clinical Impact of Bacteremia Due to Staphylococcus saprophyticus. Adv Infect Dis. 2021;11(1):6-12

  Tamura D, Hiroaki Yamane, Hikaru Tabakodani, Hirokazu Yamagishi, Erika Nakazato, Yumiko Kimura, Masayoshi Shinjoh, Takanori Yamagata.

• 12. Gallbladder cancer with ascites in a child with metachromatic leukodystrophy.Brain Dev. 2021;43(1):140-143.

  Koshu K, Ikeda T, Tamura D, Muramatsu K, Osaka H, Ono S, Adachi K, Nanba E, Nakajima T, Yamagata T.

• 13. Multifocal and extrapulmonary tuberculosis due to immunosuppressants. Pediatr Inter. 2020.

  Tamura D, Yuta Kawahara, Masaaki Mori, Takanori Yamagata.

• 14. Surfactant protein D for pathological evaluation of infant acute respiratory distress syndrome caused by respiratory virus infection. OJPED. 10(4), 2020

  Tamura D, Shun Inoue, Ayafumi Ozaki, Takatoshi Oishi, Takanori Yamagata.

• 15. Occurrence of Kawasaki disease after simultaneous immunization.Pediatr Int. 2019;61(11):1171-1173.

  Matsubara D, Minami T, Seki M, Tamura D, Yamagata T.

• 16. Hypercytokinemia with hemophagocytic syndrome due to human metapneumovirus. Pediatr Int. 2018;60:974-976.

  Tamura D, Inoue S, Kawahara Y, Mori M, Yamagata T.

• 17. Pharmacokinetics of Isoniazid-induced Rhabdomyolysis in a Girl. Intern Med. 2018;57:3501-3502.

  Kurane K, Goto M, Sano K, Noguchi K, Tamura D, Yamagata T.

• 18. A randomized, double-blind, placebo-controlled trial evaluating the safety of early oseltamivir treatment among children 0-9 years of age hospitalized with influenza in El Salvador and Panama. Antiviral Res. 2016;133:85-94.

  Dawood FS, Jara J, Gonzalez R, Castillo JM, De León T, Estripeaut D, Luciani K, Sujey Brizuela Y, Barahona A, Cazares RA, Lawson AM, Rodriguez M, de Viana D, Franco D, Castillo M, Fry AM, Gubareva L, Tamura D, Hughes M, Gargiullo P, Clara W, Azziz-Baumgartner E, Widdowson MA.

• 19. Emergence of Multidrug-Resistant Influenza A(H1N1)pdm09 Virus Variants in an Immunocompromised Child Treated With Oseltamivir and Zanamivir. J Infect Dis. 2015;212:1209-13.

  Tamura D, DeBiasi RL, Okomo-Adhiambo M, Mishin VP, Campbell AP, Loechelt B, Wiedermann BL, Fry AM, Gubareva LV.

• 20. Application of a seven-target pyrosequencing assay to improve the detection of neuraminidase inhibitor-resistant Influenza A(H3N2) viruses. Antimicrob Agents Chemother. 2015;59:2374-9.

  Tamura D, Okomo-Adhiambo M, Mishin VP, Guo Z, Xu X, Villanueva J, Fry AM, Stevens J, Gubareva LV.

• 21. Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan. J Infect Dis. 2015;211:249-57.

  Marjuki H, Mishin VP, Chesnokov AP, Jones J, De La Cruz JA, Sleeman K, Tamura D, Nguyen HT, Wu HS, Chang FY, Liu MT, Fry AM, Cox NJ, Villanueva JM, Davis CT, Gubareva LV.

• 22. Disease severity is associated with differential gene expression at the early and late phases of infection in nonhuman primates infected with different H5N1 highly pathogenic avian influenza viruses. J Virol. 2014;88:8981-97.

  Muramoto Y, Shoemaker JE, Le MQ, Itoh Y, Tamura D, Sakai-Tagawa Y, Imai H, Uraki R, Takano R, Kawakami E, Ito M, Okamoto K, Ishigaki H, Mimuro H, Sasakawa C, Matsuoka Y, Noda T, Fukuyama S, Ogasawara K, Kitano H, Kawaoka Y.

• 23. Cell culture-selected substitutions in influenza A(H3N2) neuraminidase affect drug susceptibility assessment. Antimicrob Agents Chemother. 2013;57:6141-6.

  Tamura D, Nguyen HT, Sleeman K, Levine M, Mishin VP, Yang H, Guo Z, Okomo-Adhiambo M, Xu X, Stevens J, Gubareva LV.

• 24. Two pediatric cases of Diphyllobothrium nihonkaiense infection in summer (July-August) 2010.Pediatr Int. 2012;54:163-5.

  Ikeda T, ❍Tamura D, Sato Y, Ichihashi K, Matsuoka H, Yamasaki H.

• 25. Seroprevalence of pandemic 2009 (H1N1) influenza A virus among schoolchildren and their parents in Tokyo, Japan. Clin Vaccine Immunol. 2011;18:860-6.

  Iwatsuki-Horimoto K, Horimoto T, Tamura D, Kiso M, Kawakami E, Hatakeyama S, Ebihara Y, Koibuchi T, Fujii T, Takahashi K, Shimojima M, Sakai-Tagawa Y, Ito M, Sakabe S, Iwasa A, Takahashi K, Ishii T, Gorai T, Tsuji K, Iwamoto A, Kawaoka Y.

• 26. Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors. Clin Infect Dis. 2011;52:432-7

  Tamura D, Sugaya N, Ozawa M, Takano R, Ichikawa M, Yamazaki M, Kawakami C, Shimizu H, Uehara R, Kiso M, Kawakami E, Mitamura K, Kawaoka Y.

• 27. Sensitivity of influenza rapid diagnostic tests to H5N1 and 2009 pandemic H1N1 viruses. J Clin Microbiol. 2010;48:2872-7.

  Sakai-Tagawa Y, Ozawa M, Tamura D, Le Mt, Nidom CA, Sugaya N, Kawaoka Y.

• 28. Significance of seasonal influenza viruses in the stool of pediatric patients.Pediatr Infect Dis J. 2010;29:578-9.

  Tamura D, Fujino M, Ozawa M, Iwatsuki-Horimoto K, Goto H, Sakai-Tagawa Y, Horimoto T, Nirasawa M, Kawaoka Y.

• 29. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature. 2009 Aug 20;460(7258):1021-5.

  Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, Muramoto Y, Tamura D, Sakai-Tagawa Y, Noda T, Sakabe S, Imai M, Hatta Y, Watanabe S, Li C, Yamada S, Fujii K, Murakami S, Imai H, Kakugawa S, Ito M, Takano R, Iwatsuki-Horimoto K, Shimojima M, Horimoto T, Goto H, Takahashi K, Makino A, Ishigaki H, Nakayama M, Okamatsu M, Takahashi K, Warshauer D, Shult PA, Saito R, Suzuki H, Furuta Y, Yamashita M, Mitamura K, Nakano K, Nakamura M, Brockman-Schneider R, Mitamura H, Yamazaki M, Sugaya N, Suresh M, Ozawa M, Neumann G, Gern J, Kida H, Ogasawara K, Kawaoka Y.

• 30. Oseltamivir-resistant influenza a viruses circulating in Japan. J Clin Microbiol. 2009;47:1424-7.

  Tamura D, Mitamura K, Yamazaki M, Fujino M, Nirasawa M, Kimura K, Kiso M, Shimizu H, Kawakami C, Hiroi S, Takahashi K, Hata M, Minagawa H, Kimura Y, Kaneda S, Sugita S, Horimoto T, Sugaya N, Kawaoka Y.

受賞

• 1. Best Practice Award in the Management of Pediatrics Patients with COVID-19, International COVID-19 Conference in Mongolia in 2021.

• 2. Charles C. Shepard Science Award 2016, Centers for Disease Control and Prevention.

• 3. Charles C. Shepard Science Award 2015, Centers for Disease Control and Prevention.

• 4. Larry J. Anderson Award 2015 for Outstanding Public Health Science, Centers for Disease Control and Prevention.

• 5. Charles C. Shepard Science Award 2013 for Laboratory Science, Centers for Disease Control and Prevention.

• 6. Best Presentation Award in Influenza virus infection section, The 6th Congress of Asian Society for Pediatric Research in Taiwan　2010.

• 7. Young Investigator Award 2009, Japanese Society for Pediatric Infectious Diseases.